PFIZER
DISCUSSION QUESTIONS
1. Pfizer has a long history of growth and profitability. What are some of the
major changes in the industry environment that account for recent troubles
the company has been having?
2. Does Pfizer seem to have any resource advantages relative to its major
rivals? What are the implications of your answer with regard to the future
competitiveness of the company?
3. There is a lot of price pressure on pharmaceuticals companies right now, and
it is likely to continue. What are some of the strategies firms in other
industries might use to reduce their costs (allowing them to reduce prices)?
For each of these strategies, determine whether they are likely to be effective
for a pharmaceutical company like Pfizer.
4. What are Pfizer’s options for dealing with increased government oversight
and regulation? Consumer outrage?
5. Do you see any major opportunities for Pfizer coming from the external
environment? How might Pfizer take advantage of these opportunities?
6. Pfizer sells most of its products to wholesalers. Why do you think this is the
case? Should Pfizer consider selling more of its products directly to large
pharmacy or hospital chains? Why or why not?
7. A lot of Pfizer’s growth has come from acquisitions. Would you recommend
continuing this sort of growth? Why or why not?
8. If you were Ian Read, what would you do?